Functional implications of modifying RyR-activating peptides for membrane permeability. - Wikidata - awgldk - TriplyDB

Functional implications of modifying RyR-activating peptides for membrane permeability.

Functional implications of modifying RyR-activating peptides for membrane permeability.

http://www.wikidata.org/entity/Q35048695

about

Excitation-contraction coupling from the 1950s into the new millennium.Enhancement of availability of cloricromene at brain level by a lipophilic prodrug.

P2860

Q33998846-F3E4B424-045B-4884-87AC-B87FD2EE6B32 Q48485426-CFC5E88D-9973-4A7C-B4BE-B8667735E354

P2860

Functional implications of modifying RyR-activating peptides for membrane permeability.

http://www.wikidata.org/entity/Q35048695

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Functional implications of modifying RyR-activating peptides for membrane permeability.

@ast

Functional implications of modifying RyR-activating peptides for membrane permeability.

@en

type

label

Functional implications of modifying RyR-activating peptides for membrane permeability.

@ast

Functional implications of modifying RyR-activating peptides for membrane permeability.

@en

prefLabel

Functional implications of modifying RyR-activating peptides for membrane permeability.

@ast

Functional implications of modifying RyR-activating peptides for membrane permeability.

@en

P1433

Q35048695-19415F6B-D9CC-4792-947D-31E45C3AF7E2

P1476

Q35048695-8304D1AC-14E6-44B4-A6EF-B53B3AA7FED9

P2093

Q35048695-2CC4CAA1-03F9-4BC5-8A26-EF58A838F771

Q35048695-8D5342D4-A7D8-4A1E-AE6F-96D68ACEEB26

Q35048695-985342AF-8A49-42A2-8FED-4585109F5A97

Q35048695-B32253DD-7A8C-4339-96A8-DA53D0AAB582

Q35048695-EA4D05CB-6498-46DA-B837-E472236D1CAC

Q35048695-EACFFDD6-B700-4218-A448-2D6751B16C49

Q35048695-F36E1351-609E-468C-941A-5438C16F5AC4

P2860

Q35048695-0182AEA1-1E04-459E-8961-FA046EA138EC

Q35048695-1AB3406C-9B19-4C0A-9D2E-C1AEACF6EF95

Q35048695-2ED10804-98E0-4040-8551-AE3E61D7AA9D

Q35048695-340E2A59-9180-4311-92AF-1927DFC73EC7

Q35048695-45204E73-40DC-40AA-8516-365B4551C557

Q35048695-47E4361D-6A1B-4ED0-B758-60230A6F312B

Q35048695-510A19D5-4E21-4DA0-AC33-CDA91BB3C5DA

Q35048695-6D59C94B-ED89-4A6C-9CCF-A81F7AF6F3B3

Q35048695-70C18C3D-9EBF-4670-8EF1-72927FB43C75

Q35048695-8FE716E5-BBC7-474F-8CFB-0DD4863F7779

P304

Q35048695-4E2F5E4F-A2A9-4F98-ADC9-497B1299AD08

P31

Q35048695-71ADF3DF-4B0C-426D-B54B-2663349D24BE

P356

Q35048695-54FB263A-D8F1-4925-AC13-1264599D0779

P407

Q35048695-26F5D13A-B018-4FAD-840D-C2B3462454F8

P433

Q35048695-4F430175-0557-455A-8B7C-4D7DEC7788F7

P478

Q35048695-3B5CF900-F1E6-4248-8A05-ECE514B0D4F0

P50

Q35048695-B7ADE930-2926-4A95-ADA7-3CF0D9EE2A64

Q35048695-F8277390-0FD4-48F1-87D9-7A460AF30004

Q35048695-F9C37CA8-8AEB-4312-A6F5-9C56B0D9BD38

P577

Q35048695-B99C9357-15F7-460A-BD0D-E2ED79FADE38

P5875

Q35048695-7AA267F2-F8C1-45C1-A446-35824589D909

P698

Q35048695-E8091895-B578-43C9-9ADF-9EB26F7F2643

P932

Q35048695-1B6F18AC-232A-4463-B995-BF29FD1E75D9

P356

P1433

British Journal of Pharmacology

P1476

Functional implications of modifying RyR-activating peptides for membrane permeability

@en

P2093

Graham D Lamb

http://www.w3.org/2001/XMLSchema#string

Jacqui Young

http://www.w3.org/2001/XMLSchema#string

Louise Cengia

http://www.w3.org/2001/XMLSchema#string

Marco G Casarotto

http://www.w3.org/2001/XMLSchema#string

Norbert Wimmer

http://www.w3.org/2001/XMLSchema#string

Suzy M Pace

http://www.w3.org/2001/XMLSchema#string

Yiu-Ngok Chan

http://www.w3.org/2001/XMLSchema#string

P2860

A structural requirement for activation of skeletal ryanodine receptors by peptides of the dihydropyridine receptor II-III loop

A new fold in the scorpion toxin family, associated with an activity on a ryanodine-sensitive calcium channel

The three-dimensional structural surface of two beta-sheet scorpion toxins mimics that of an alpha-helical dihydropyridine receptor segment

Two domains in dihydropyridine receptor activate the skeletal muscle Ca(2+) release channel.

Different Ca2+ releasing action of caffeine and depolarisation in skeletal muscle fibres of the rat

A component of excitation-contraction coupling triggered in the absence of the T671-L690 and L720-Q765 regions of the II-III loop of the dihydropyridine receptor alpha(1s) pore subunit.

Structural determinants for activation or inhibition of ryanodine receptors by basic residues in the dihydropyridine receptor II-III loop.

A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules

Caco-2 monolayers in experimental and theoretical predictions of drug transport.

Activation and inhibition of skeletal RyR channels by a part of the skeletal DHPR II-III loop: effects of DHPR Ser687 and FKBP12.

P304

743-754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0705981

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

144

http://www.w3.org/2001/XMLSchema#string

P50

Angela F Dulhunty

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7955754

http://www.w3.org/2001/XMLSchema#string

P698

15778698

http://www.w3.org/2001/XMLSchema#string

P932

1576055

http://www.w3.org/2001/XMLSchema#string